Spok Holdings, Inc. (SPOK): Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati
Spok Holdings, Inc. (SPOK) AQSh kliniklari uchun radio minoralar va favqulodda aloqa dasturiy ta'minotining noyob tarmog'ini boshqaradi. PEG koeffitsiyenti biznesning baholanish dinamikasini aks ettiradi, bunda 0.00 ushbu ko'rsatkichning joriy darajasini ifodalaydi. Kritik aloqa sohasidagi yetakchi maqomi shifoxonalar orasida yuqori sodiqlikni ta'minlaydi. Qarzning yo'qligi va monopol pozitsiya favqulodda moliyaviy barqarorlikni hamda barqaror foyda generatorini yaratadi.
%20Narxning%20foydaga%20va%20o%E2%80%98sish%20sur%E2%80%99atiga%20nisbati&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_SPOK_-_Spok-Holdings-Inc._-_PriceEarnings-to-Growth-Ratio "O‘sish sur’atiga tuzatilgan narx-foyda: Spok (SPOK) 04.07.2022 - 15.11.2026 uchun | 👁️GURU.Markets👁️")
Spok (SPOK) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Spok Holdings, Inc.|SPOK - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Spok Holdings Inc|SPOK - Kompaniya qarzlari|Balans qiymatiga qarzlar Spok|SPOK - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Spok|Shoshilinch likvidlik koeffitsiyenti spok.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
SPOK - Sof foyda|Kompaniya foydasi prognozi Spok Holdings, Inc.|SPOK - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Spok Holdings, Inc.|SPOK - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati multiplikatori Spok|SPOK - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Spok|SPOK - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi spok.com|SPOK - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Spok Holdings, Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:SPOK - USA Mobility
Investorlar yashirin o'sish potentsialini aniqlash uchun bozor kapitalizatsiyasini foyda dinamikasi bilan solishtirib, emitentning barqarorligini tekshirmoqdalar. EPS o'sishiga nisbatan P/E koeffitsiyentini tahlil qilish orqali Spok Holdings, Inc. (SPOK) baholashlarining adolatli ekanligini baholash mumkin, bunda mahalliy kontragentlar orqali tibbiy uskunalar ta'minotining barqarorligi risklarni minimallashtiradi, bu esa birdan past qiymatlarni aktivning o'sish sur'atlariga nisbatan fundamental past baholanganligining kuchli signali sifatida namoyon etadi.
Spok Holdings, Inc. raqobatchilari
Narxning foydaga va o‘sish sur’atiga nisbati VEEV (Veeva Systems Inc)|Narxning foydaga va o‘sish sur’atiga nisbati Doximity Inc DOCS|PEG multiplikatori healthequity.com HQY|WAY - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CRVL (CorVel Healthcare)|PRVA (Privia Health Corp) - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Huron Corp (HURN)|CERT (Certara Software) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Omnicell, Inc. (OMCL)|Narx-foyda va o‘sish multiplikatori GDRX (GoodRx Corp)|Schrödinger - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori PHR (Phreesia Inc)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti OMDA|Evolent Health, Inc. - PEG multiplikatori|healthstream.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|DH (Definitive Healthcare Corp.) - Narx-foyda va o‘sish multiplikatori|CCSI - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati agilon health Inc|Absci (ABSI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori SY|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati National Research|PEG multiplikatori OPRX (OptimizeRx Corp)|TBRG: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|SLP - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati sophiagenetics.com SOPH|healthcatalyst.com (HCAT) - Narxning foydaga va o‘sish sur’atiga nisbati|CCLD - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|RSSS (researchsolutions.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda dlhcorp.com DLHC|Narxning foydaga va o‘sish sur’atiga nisbati OneMedNet Corp (ONMD)|Scienture Holdings Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori HCTI (Healthcare Triangle Corporation)|ISPC (iSpecimen Corp) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|BFRG - Narxning foydaga va o‘sish sur’atiga nisbati|SCWorx Corporation - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|MSP Recovery (MSPR) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori iCoreConnect, Inc.|MEDS (TRxADE HEALTH Inc) - PEG multiplikatori|ORGS (Orgenesis) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori RCM (R1 RCM, Inc.)|SHCR (Sharecare Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Streamline Health Solutions, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Syra Health Corp. (SYRA)|AMEH - Narxning foydaga va o‘sish sur’atiga nisbati|modeln.com (MODN) - Narx-foyda va o‘sish multiplikatori|NXGN (NextGen Healthcare) - Narx-foyda va o‘sish multiplikatori
